RenovoRx Announces Pricing of Initial Public Offering

/PRNewswire/ -- RenovoRx, Inc., a biopharmaceutical company and innovator in targeted cancer therapy, today announced the pricing of its underwritten initial...

Related Keywords

California ,United States ,Newport Beach , ,Maxim Group ,Drug Delivery Technology ,Roth Capital Partners ,Capital Partners ,Clemente Drive ,Equity Capital Markets ,Silicon Valley ,Renovorx Trans Arterial Micro Perfusion ,Orphan Drug Designations ,Fierce Innovation Awards ,Renovorx ,